ApprovalTrail

Approval · Notice of Compliance 4693 · 1996

Notice of Compliance 4693

Issued May 24, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4693
Date
May 24, 1996
Company
Mallinckrodt MedicalAthlone, WM, Ireland
Product type
Radiopharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
Modification of packaging system
Therapeutic class
Radiodiagnostic agent

Products in this notice

None listed.